JP2016512693A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2016512693A5 JP2016512693A5 JP2016503010A JP2016503010A JP2016512693A5 JP 2016512693 A5 JP2016512693 A5 JP 2016512693A5 JP 2016503010 A JP2016503010 A JP 2016503010A JP 2016503010 A JP2016503010 A JP 2016503010A JP 2016512693 A5 JP2016512693 A5 JP 2016512693A5
- Authority
- JP
- Japan
- Prior art keywords
- reagent
- providing
- cell
- tissue sample
- chaotrope
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US201361798627P | 2013-03-15 | 2013-03-15 | |
| US61/798,627 | 2013-03-15 | ||
| PCT/US2014/029198 WO2014144682A1 (en) | 2013-03-15 | 2014-03-14 | Methods and reagents for maintaining the viability of cancer cells in surgically removed tissue |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| JP2016512693A JP2016512693A (ja) | 2016-05-09 |
| JP2016512693A5 true JP2016512693A5 (https=) | 2017-04-13 |
| JP6465857B2 JP6465857B2 (ja) | 2019-02-06 |
Family
ID=51528685
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2016503010A Active JP6465857B2 (ja) | 2013-03-15 | 2014-03-14 | 外科的に摘出された組織における癌細胞の生存能を維持するための方法および試薬 |
Country Status (17)
| Country | Link |
|---|---|
| US (5) | US9113623B2 (https=) |
| EP (2) | EP3581643A1 (https=) |
| JP (1) | JP6465857B2 (https=) |
| CN (2) | CN105121629B (https=) |
| CA (1) | CA2941929C (https=) |
| CY (1) | CY1120801T1 (https=) |
| DK (1) | DK2970878T3 (https=) |
| ES (1) | ES2684582T3 (https=) |
| HR (1) | HRP20181352T1 (https=) |
| HU (1) | HUE039933T2 (https=) |
| LT (1) | LT2970878T (https=) |
| PL (1) | PL2970878T3 (https=) |
| PT (1) | PT2970878T (https=) |
| RS (1) | RS57900B1 (https=) |
| SI (1) | SI2970878T1 (https=) |
| SM (1) | SMT201800457T1 (https=) |
| WO (1) | WO2014144682A1 (https=) |
Families Citing this family (6)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| ES2684582T3 (es) | 2013-03-15 | 2018-10-03 | Truckee Applied Genomics, Llc | Métodos y reactivos para mantener la viabilidad de células cancerosas en tejido eliminado quirúrgicamente |
| CN107002063A (zh) | 2014-11-25 | 2017-08-01 | 生物辐射实验室股份有限公司 | 精氨酸提高聚合酶储存稳定性 |
| CN107333750A (zh) * | 2017-06-11 | 2017-11-10 | 成都吱吖科技有限公司 | 一种长时血液细胞稳定剂 |
| EP4089180B1 (en) | 2019-09-17 | 2025-06-25 | Longhorn Vaccines and Diagnostics, LLC | Multipurpose compositions for collecting and transporting biological material |
| WO2022010916A1 (en) * | 2020-07-07 | 2022-01-13 | Truckee Applied Genomics, Llc | Cell preservation reagents and methods of use |
| CN117063915B (zh) * | 2023-08-17 | 2026-02-24 | 镜像绮点(上海)细胞技术有限公司 | 原代肿瘤细胞冻存液 |
Family Cites Families (23)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US5409826A (en) * | 1993-06-08 | 1995-04-25 | Coulter Corporation | Preserved, non-infectious control cells prepared by the modulation or modification of normal cells |
| JP2000509018A (ja) * | 1996-03-26 | 2000-07-18 | イーライ・リリー・アンド・カンパニー | 肥満タンパク質製剤 |
| US20010007673A1 (en) | 1999-11-12 | 2001-07-12 | Merrill Seymour Goldenberg | Sustained-release delayed gels |
| US7569342B2 (en) | 1997-12-10 | 2009-08-04 | Sierra Molecular Corp. | Removal of molecular assay interferences |
| US20080064108A1 (en) | 1997-12-10 | 2008-03-13 | Tony Baker | Urine Preservation System |
| WO1999029904A2 (en) | 1997-12-10 | 1999-06-17 | Sierra Diagnostics, Inc. | Methods and reagents for preservation of dna in bodily fluids |
| WO2002046368A1 (fr) * | 2000-12-04 | 2002-06-13 | Humantec Ltd. | Liquide de conservation de cellules et procede de conservation de cellules dans lequel ledit liquide est utilise |
| KR20020066778A (ko) | 2001-02-13 | 2002-08-21 | 한국과학기술연구원 | 체내 난흡수 물질의 흡수촉진용 조성물과 제형 및 그의제조방법 |
| WO2008111981A1 (en) | 2007-03-14 | 2008-09-18 | Sierra Molecular Corporation | Compositions, systems, and methods for preservation of macromolecules |
| AU2003300899A1 (en) * | 2002-12-12 | 2004-06-30 | Oncotech, Inc. | Genes related to sensitivity and resistance to chemotherapeutic drug treatment |
| US8793895B2 (en) * | 2006-02-10 | 2014-08-05 | Praxair Technology, Inc. | Lyophilization system and method |
| CN101617045A (zh) | 2006-09-12 | 2009-12-30 | 谢拉分子公司 | 使用离液剂的缓冲溶液去除核酸的分子分析干扰物 |
| US8080645B2 (en) * | 2007-10-01 | 2011-12-20 | Longhorn Vaccines & Diagnostics Llc | Biological specimen collection/transport compositions and methods |
| US8652782B2 (en) * | 2006-09-12 | 2014-02-18 | Longhorn Vaccines & Diagnostics, Llc | Compositions and methods for detecting, identifying and quantitating mycobacterial-specific nucleic acids |
| JP2010508090A (ja) | 2006-10-27 | 2010-03-18 | シエラ モレキュラー コーポレイション | 貫通可能な隔壁キャップ |
| ES2394815T3 (es) | 2006-12-13 | 2013-02-05 | F. Hoffmann-La Roche Ag | Utilización de TDE para el aislamiento de ácidos nucleicos |
| AU2008224883A1 (en) | 2007-03-14 | 2008-09-18 | Sierra Molecular Corporation | Compositions, systems, and methods for preservation and/or stabilization of a cell and/or macromolecule |
| KR20100102607A (ko) * | 2007-11-12 | 2010-09-24 | 바이파 사이언스 인코포레이티드 | Ｐａｒｐ 억제제를 단독으로 사용하거나 항종양제와 병용하여 자궁암 및 난소암을 치료하는 방법 |
| US20100003748A1 (en) * | 2008-07-03 | 2010-01-07 | Tony Baker | Compositions, systems, and methods for stabilization of a cell and/or macromolecule |
| WO2010028156A2 (en) | 2008-09-04 | 2010-03-11 | Board Of Regents, The University Of Texas System | Dual modality detection of apoptosis |
| US9133343B2 (en) | 2009-11-30 | 2015-09-15 | Enzo Biochem, Inc. | Dyes and compositions, and processes for using same in analysis of protein aggregation and other applications |
| CN102318597B (zh) * | 2011-08-19 | 2013-04-03 | 张雪云 | 一种液基细胞保存液组合物及其制备方法 |
| ES2684582T3 (es) | 2013-03-15 | 2018-10-03 | Truckee Applied Genomics, Llc | Métodos y reactivos para mantener la viabilidad de células cancerosas en tejido eliminado quirúrgicamente |
-
2014
- 2014-03-14 ES ES14763797.9T patent/ES2684582T3/es active Active
- 2014-03-14 CA CA2941929A patent/CA2941929C/en active Active
- 2014-03-14 CN CN201480014875.5A patent/CN105121629B/zh active Active
- 2014-03-14 HU HUE14763797A patent/HUE039933T2/hu unknown
- 2014-03-14 DK DK14763797.9T patent/DK2970878T3/en active
- 2014-03-14 PL PL14763797T patent/PL2970878T3/pl unknown
- 2014-03-14 PT PT14763797T patent/PT2970878T/pt unknown
- 2014-03-14 RS RS20180976A patent/RS57900B1/sr unknown
- 2014-03-14 LT LTEP14763797.9T patent/LT2970878T/lt unknown
- 2014-03-14 US US14/211,578 patent/US9113623B2/en active Active
- 2014-03-14 WO PCT/US2014/029198 patent/WO2014144682A1/en not_active Ceased
- 2014-03-14 EP EP18173516.8A patent/EP3581643A1/en not_active Withdrawn
- 2014-03-14 EP EP14763797.9A patent/EP2970878B1/en active Active
- 2014-03-14 CN CN202011428224.4A patent/CN112806352A/zh active Pending
- 2014-03-14 SM SM20180457T patent/SMT201800457T1/it unknown
- 2014-03-14 HR HRP20181352TT patent/HRP20181352T1/hr unknown
- 2014-03-14 JP JP2016503010A patent/JP6465857B2/ja active Active
- 2014-03-14 SI SI201430839T patent/SI2970878T1/sl unknown
-
2015
- 2015-05-01 US US14/702,643 patent/US9565852B2/en active Active
- 2015-05-14 US US14/712,750 patent/US9445586B2/en active Active
-
2016
- 2016-02-02 US US15/013,541 patent/US9949474B2/en active Active
-
2017
- 2017-02-13 US US15/431,478 patent/US10772318B2/en active Active
-
2018
- 2018-08-23 CY CY181100877T patent/CY1120801T1/el unknown
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2016512693A5 (https=) | ||
| FIC20250001I1 (en) | Modified factor ix, and compositions, methods and uses for gene transfer to cells, organs and tissues | |
| EP3310931A4 (en) | CRISPR / CAS9 COMPLEX FOR INTRODUCING A FUNCTIONAL POLYPEPTIDE IN CELLS OF A BLOOD CELL LINE | |
| EP4265250A3 (en) | Solid forms of an ask1 inhibitor | |
| HRP20260181T1 (hr) | Priprema i skladištenje lipozomskih rnk formulacija koje su pogodne za terapiju | |
| JP2016520647A5 (https=) | ||
| MX2016010266A (es) | Formas solidas cristalinas de n-{4-[(6,7-dimetoxiquinolin-4-il)oxi ]fenil}-n'-(4-fluorofenil)ciclopropan-1,1-dicarboxamida, procesos para elaboracion y metodos de uso. | |
| EA201691826A1 (ru) | Способ использования графена и других двухмерных материалов in vivo и in vitro | |
| CL2016003324A1 (es) | Construcciones de anticuerpos multiespecificos. | |
| EP3564356A4 (en) | SOLUTION FOR CRYOPRESERVATION, CRYOGENIZATION PRODUCT, AND METHOD FOR CRYOPRESERVATION OF ANIMAL CELLS OR ANIMAL TISSUES | |
| BR112015021189A2 (pt) | métodos de banco de células de alta densidade | |
| JP2015061520A5 (https=) | ||
| NZ739339A (en) | Apoptosis signal-regulating kinase inhibitor | |
| SI2958913T1 (sl) | Sfingozin-1-fosfat receptor agonisti, postopki za njegovo pripravo in farmacevtski sestavki, ki ga vsebujejo kot aktivno sredstvo | |
| AR090903A1 (es) | Anticuerpos e inmunoconjugados anti-pmel17 | |
| WO2015153772A3 (en) | Zirconium-89 oxine complex as a cell labeling agent for positron emission tomography | |
| EP3202409A4 (en) | Composition, cell construct, islet transplant kit, islet cell transplant therapeutic agent and blood sugar reducing agent, composition including islets, kit including islets, and islet transplant therapeutic agent and blood sugar reducing agent | |
| DK3232780T3 (da) | Vandige adjuvans-sammensætninger, der indeholder elektrolyt, sammensætninger, som indeholder et aktivt stof, og anvendelse deraf | |
| MX2013006188A (es) | Agentes de generacion de imagenes pet de apoptosis. | |
| BR112013021784A2 (pt) | composição de reagente, e, método para a recuperação de um metal de uma solução aquosa | |
| EP3727585C0 (en) | SYSTEM FOR INDUCING SONOPERMEABILIZATION TRANSFER OF A DRUG INTO CANCER CELLS | |
| EP2692772A4 (en) | POLYETHERIC COMPOUND AND ELECTROLYTE COMPOSITION | |
| FR3033335B1 (fr) | Procede non radioactif de determination de l'action cytolytique d'un agent vis-a-vis de cellules cibles, son utilisation et kit associe | |
| WO2015171826A8 (en) | Steap3 as a biochemical marker of red blood cell storage and toxicity | |
| GB201803419D0 (en) | Complex for the delivery of cas9 proteins guide RNA to cells |